Reliance eyes Jio-style disruption in genomics with sub-Rs 1,000 tests

The energy-to-retail conglomerate is leveraging Strand Life Sciences for its entry into the emerging areas of specialised healthcare diagnostics and genomic sciences. Reliance had acquired the Bengaluru-based company for ₹393 crore in 2021.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LZk9Cp5
via IFTTT